ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells.

Hung C Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.